Product References — Proteins

Innovative Research's Human Receptor Associated Protein (RAP) was recently used in the following study: CD91 interacts with mannan-binding lectin (MBL) through the MBL-associated serine protease-binding siteK Duus, NM Thielens, M Lacroix, P Tacnet... - FEBS ..., 2010 - Wiley Online Library...Sigma. Human placenta-derived CD91 was from BioMac (Chamalires, France). RAP was from Innovative Research (Novi, Michigan, USA). Recombinant MBL was a generous gift of NatImmune (Kbenhavn , Denmark).

Innovative Research's Human Activated Protein C was recently used in the following study: FV Leiden pseudo-homozygotes have a more pronounced hypercoagulable state than FV Leiden homozygotesC Duckers, P Simioni, D Tormene... - ... of bleeding tendency ..., 2011 - arno.unimaas.nl...was added to inhibit contact activation. Measurements at high TF were Page 114. Chapter 6 114 performed in the absence and presence of APC (Innovative Research, Novi, MI, USA). Since the low APC concentration (~ 5 nM...

Innovative Research's Balb C Mouse IgG Protein A Purified was recently used in the following study: Granzyme B is a novel interleukin-18 converting enzymeY Omoto, K Yamanaka, K Tokime, S Kitano... - Journal of ..., 2010 - Elsevier...And then their products were analyzed with or without 10 ng/ml of mouse anti-human neutralizing mAb (clone 125-2H, MBL) or 10 ng/ml of Balb c mouse IgG control antibody (Innovative Research, Novi, MI) by IFN-? induction assay.

Innovative Research's Rat IgG, Protein A Purified was recently used in the following study: B cells limit repair after ischemic acute kidney injuryHR Jang, MT Gandolfo, GJ Ko, SR Satpute... - Journal of the ..., 2010 - Am Soc Nephrol...Tokyo, Japan). Control Ig (rat IgG) was purchased from Innovative Research (Novi, MI). Both MR16-1 and control IgG were diluted with sterile normal saline, and 50 mg/kg of each was administered into the peritoneal cavity every 5 days starting at day 1 after renal IRI.

Innovative Research's Human Coagulation Factor XIII was recently used in the following study: Cohesive behavior of soft biological adhesives: Experiments and modelingAK Dastjerdi, M Pagano, MT Kaartinen... - Acta ..., 2012 - barthelat-lab.mcgill.ca...Fibrin was prepared as de- scribed above, and crosslinking of fibrin was induced by adding human Factor XIII (Innovative Research, Novi, MI, USA) to the fibrinogen solution and then combining and mixing it with the thrombin solution. In addition to inducing fibrin formation from...